Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02662062 |
Title | Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer (PCR-MIB) |
Acronym | PCR-MIB |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Australian and New Zealand Urogenital and Prostate Cancer Trials Group |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Chris O'Brien Lifehouse | Camperdown | New South Wales | 2050 | Australia | Details | |
Liverpool Hospital | Liverpool | New South Wales | 2170 | Australia | Details | |
Prince of Wales Hospital | Randwick | New South Wales | 2013 | Australia | Details | |
Royal North Shore Hospital | St Leonards | New South Wales | 2065 | Australia | Details | |
Austin Health | Heidelberg | Victoria | 3084 | Australia | Details | |
Peter MacCallum Cancer Centre | Melbourne | Victoria | 3002 | Australia | Details | |
Sir Charles Gairdner Hospital | Nedlands | Western Australia | 6009 | Australia | Details |